JW Asset Management

JW Asset Management is a New York-based investment firm founded in 1998, specializing in the healthcare sector, among others. The firm operates three hedge funds and two private equity funds, focusing on sector-oriented equity and event-driven investment strategies. Its asset exposure spans equities, derivatives, and both corporate and sovereign fixed income. JW Asset Management is known for its active role in significant transactions, having led the investor group in the acquisition of Arbor Pharmaceuticals, Inc. in 2010 and serving as the lead investor in TerrAscend Corp. Additionally, the firm seeks opportunities within the pharmaceutical, agricultural technology, banking, cannabis, consumer, retail, medical, health, and wellness sectors. As a Registered Investment Adviser, JW Asset Management employs a volatility style preference to guide its investment decisions.

Jason Klarreich

Executive Vice President and CFO

Tim Seymour

Managing Director

22 past transactions

Tyson 2.0

Series A in 2022
Tyson 2.0 is a cannabis company producing cannabis products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates, and consumables available at retailers nationwide. The company is formed by the legendary boxer, entrepreneur, and icon Mike Tyson.

Allumia

Series A in 2022
Allumia, LLC designs, funds, installs, and manages lighting upgrades. It evaluates the current lighting and follow-up with a proposal, which includes updated designs and expected savings; installs and upgrades the entire facility’s lighting; and provides replacement lamps, drivers, and additional lighting hardware; and maintenance services. The company serves commercial, athletic, automotive, and industrial markets. Allumia, LLC was founded in 2013 and is based in Seattle, Washington. It has additional satellite offices in Los Angeles, California and Durham, North Carolina.

Pistil Data

Seed Round in 2021
Pistil Data is a well-funded, early stage data technology startup. Founded by executives from Google, Twitter and Intel, Pistil Data is developing SaaS data services for one of the fastest growing industries in the world: cannabis. We are unique in our application of cutting-edge technology to an industry that has increasing needs for data and insight. Our goal is to be the leading data platform for cannabis, and help every cannabis business find new opportunities to grow.

Fyllo

Series C in 2021
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

CityRow

Series A in 2021
CityRow Holdings, Inc. specializes in health and fitness services, offering a unique blend of workouts that include yoga, strength training, and cardio, primarily utilizing water-based rowing machines. Founded in 2014 and headquartered in New York City, the company operates three locations in Michigan and New York. CityRow also provides a digital platform, Cityrow Go, which is a rowing-based fitness app designed for smartphones and tablets. This app features a variety of rowing classes aimed at delivering effective and motivating workouts for users at home. The studio's approach focuses on enhancing aerobic capacity and overall body efficiency through high-intensity interval training that emphasizes low-impact exercises, helping individuals achieve their fitness goals in a scientifically guided manner.

Fyllo

Series B in 2021
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

Gage Cannabis

Venture Round in 2020
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Fyllo

Series A in 2020
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

High 12

Series A in 2019
High 12 is a consumer packaged goods company based in Toronto, Canada, established in 2018. The company specializes in the cannabis sector, focusing on the development and operation of prominent global cannabis brands. High 12 emphasizes a consumer-centric approach to product creation and launch, utilizing data-driven analysis to ensure the success and recognition of its brands. By building strong brand identities, High 12 aims to foster a sense of community and connection among users, highlighting the shared social fabric associated with cannabis consumption. Additionally, the company seeks to develop strategic supply-chain partnerships to enhance its operational efficiency and brand offerings.

Canndescent

Series C in 2019
Canndescent LLC is a cannabis cultivator based in Santa Barbara, California, specializing in the production of premium cannabis flowers. The company adheres to state compliance regulations and focuses on quality management and cultivation expertise. By moving away from traditional strain names, Canndescent aims to simplify the customer experience, offering products that are cultivated, packaged, and distributed in accordance with all relevant state and local laws.

Fyllo

Seed Round in 2019
Fyllo Inc. is a marketing technology company that specializes in serving the cannabis industry. Founded in 2019 and headquartered in Chicago, Illinois, with additional offices in major cities across North America and Israel, Fyllo offers a comprehensive platform designed to address the unique challenges of this highly regulated market. The Fyllo Compliance Cloud provides enterprise-grade software and services, leveraging RegsTechnology's extensive database of cannabis laws and regulations at various governmental levels. Fyllo's solutions encompass data analytics, ad campaign management, measurement and reporting, and creative management services, enabling marketers and legal professionals to navigate compliance complexities while driving growth and engagement.

Henry's Original

Series B in 2019
Henry's Original is a producer of handcrafted cannabis products sourced from family-run farms in Mendocino County. Established in mid-2017, the company focuses on creating high-quality offerings for the health and wellness industry, including flower, pre-rolls, singles, and flower vape cartridges. Henry's Original emphasizes organic cultivation, ensuring its products meet and exceed California State standards. This commitment to quality has garnered attention from various media outlets, including the Los Angeles Times and Men's Journal, highlighting its dedication to providing consumers with premium, sustainably-grown cannabis directly from the farm.

GrowGeneration

Post in 2019
GrowGeneration is a private company, whose plan is to open and operate hydroponic and specialty gardening stores and capitalize on the rapid growth from the legalization of marijuana and home gardening. The company is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems, and accessories for hydroponic gardening.

Vitruvias Therapeutics

Series A in 2018
Vitruvias Therapeutics is a start-up generic pharmaceutical company based in Montgomery, Alabama, founded in 2013. The company specializes in developing niche topical generic products that are available only by prescription. Focusing on complex active pharmaceutical ingredients (APIs) and challenging finished dosage forms, Vitruvias Therapeutics aims to address the difficulties associated with manufacturing these products. By leveraging strategic partnerships, the company seeks to overcome manufacturing complexities and raw material sourcing challenges, thereby enhancing the availability of essential generic medications. The name Vitruvias is inspired by Leonardo da Vinci’s "Vitruvian Man," symbolizing the ideal proportions of the human figure, reflecting the company's commitment to precision in pharmaceutical development.

TerrAscend

Post in 2017
TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations, and Terra Health Network Inc., a provider of clinical support and education programs led by health care professionals.

Vensun Pharmaceuticals

Series C in 2016
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, focused on developing a diverse portfolio of generic prescription products across various therapeutic categories and dosage forms. Established in 2011, Vensun actively collaborates with strategic partners both domestically and internationally to co-develop its products. The company has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is also seeking further partnerships, strategic alliances, and product acquisitions to expand its development portfolio, aiming to provide enhanced pharmaceutical options for clinicians and healthcare professionals in the U.S. generic market.

Establishment Labs

Debt Financing in 2016
Establishment Labs is a medical technology company headquartered in Alajuela, Costa Rica, specializing in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a diverse range of breast implants with various options for surface, shape, size, base, and projection. In addition to implants, Establishment Labs provides advanced solutions such as the Divina 3D surgical simulation system for pre-surgical consultations and the Puregraft technology for autologous fat harvesting and redistribution. The company operates globally, selling its products through exclusive distributors and a direct sales force in over 80 countries, while maintaining compliance with both FDA and ISO standards. Establishment Labs emphasizes innovation and quality assurance throughout its manufacturing processes, ensuring that its products meet the highest safety and performance standards.

Establishment Labs

Venture Round in 2015
Establishment Labs is a medical technology company headquartered in Alajuela, Costa Rica, specializing in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants, primarily under the Motiva Implants brand. The company offers a diverse range of breast implants with various options for surface, shape, size, base, and projection. In addition to implants, Establishment Labs provides advanced solutions such as the Divina 3D surgical simulation system for pre-surgical consultations and the Puregraft technology for autologous fat harvesting and redistribution. The company operates globally, selling its products through exclusive distributors and a direct sales force in over 80 countries, while maintaining compliance with both FDA and ISO standards. Establishment Labs emphasizes innovation and quality assurance throughout its manufacturing processes, ensuring that its products meet the highest safety and performance standards.
Aralez Pharmaceuticals is a specialty pharmaceutical company that focuses on the acquisition, development, and commercialization of products primarily in cardiovascular health, pain management, and other specialty areas. The company offers a range of products, including Fiorinal, Proferrin, Fibricor, Uracyst, Neovisc, and Cambia, among others. Operating mainly in the United States and Canada, Aralez generates the majority of its revenue from the U.S. market, serving customers worldwide with its innovative therapeutic solutions.

Vensun Pharmaceuticals

Series B in 2013
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, focused on developing a diverse portfolio of generic prescription products across various therapeutic categories and dosage forms. Established in 2011, Vensun actively collaborates with strategic partners both domestically and internationally to co-develop its products. The company has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is also seeking further partnerships, strategic alliances, and product acquisitions to expand its development portfolio, aiming to provide enhanced pharmaceutical options for clinicians and healthcare professionals in the U.S. generic market.

Vensun Pharmaceuticals

Series A in 2012
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, focused on developing a diverse portfolio of generic prescription products across various therapeutic categories and dosage forms. Established in 2011, Vensun actively collaborates with strategic partners both domestically and internationally to co-develop its products. The company has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is also seeking further partnerships, strategic alliances, and product acquisitions to expand its development portfolio, aiming to provide enhanced pharmaceutical options for clinicians and healthcare professionals in the U.S. generic market.

Arbor Pharmaceuticals

Series B in 2010
Arbor Pharmaceuticals is a specialty pharmaceutical company based in Raleigh, North Carolina, established in 2006. The company focuses on pediatric medicine, engaging in the licensing, development, and commercialization of late-stage products aimed at treating common pediatric conditions. Its product portfolio includes treatments for acute otitis externa and acute otitis media, such as ZINOTIC and NEOTIC, as well as XYLAREX for dietary management of recurrent acute otitis media. Additionally, Arbor Pharmaceuticals offers the Pediaderm HC Complete Kit for children with atopic dermatitis. The company utilizes specialized sales forces to market its products throughout the United States, while also having interests in cardiology, neurology, endocrinology, and orphan products, providing safe and effective medications that aim to improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.